Increasing Reoperations and Failures With Increasing BMI in Patients Undergoing 2-Stage Exchange for Infected Total

Yehuda E Kerbel1, Gregory J Kirchner2, Ariana T Meltzer-Bruhn1

  • 1Dept of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA.

Abstract

Insights

Morbidly obese patients face higher risks of reinfection and reoperation after two-stage prosthetic joint infection (PJI) reimplantation. This highlights the need for pre-operative optimization in this patient group undergoing hip arthroplasty.

Area of Science:

  • Orthopedic surgery
  • Infectious disease
  • Obesity research

Background:

  • Morbid obesity is linked to higher infection rates after total hip arthroplasty.
  • Limited data exists on outcomes of two-stage reimplantation for prosthetic joint infection (PJI) in morbidly obese patients.

Purpose of the Study:

  • To evaluate the impact of morbid obesity (BMI > 40 kg/m2) on reinfection, complications, readmissions, and reoperations after two-stage hip PJI reimplantation.

Main Methods:

  • Retrospective review of 107 patients undergoing first-time two-stage PJI reimplantation (2013-2019).
  • Propensity score matching created three cohorts: nonobese (<30 kg/m2), obese (30-39.9 kg/m2), and morbidly obese (>40 kg/m2).
  • Outcomes compared using chi-square or Fisher's exact tests with minimum 12-month follow-up.

Main Results:

  • Morbidly obese patients had higher reinfection rates (33% vs 0% in nonobese, P=.020) and longer hospital stays (>4 days, 61% vs 19%, P=.012).
  • Morbidly obese patients showed increased return to OR rates (50% vs 13-19%, P=.020).
  • No significant differences noted in overall complications, mortality, or revision surgery rates between groups.

Conclusions:

  • Morbidly obese patients experience significantly higher risks of reinfection and reoperation following two-stage PJI reimplantation.
  • Findings suggest counseling morbidly obese patients on increased risks and considering delayed arthroplasty pending optimization.
  • This study provides crucial data for managing PJI in morbidly obese individuals undergoing hip arthroplasty.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
131
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
677
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
98